
Cardinal Drug Limited
Pharmaceutical company specializing in drugs and medicines.
Pharmaceutical company specializing in drugs and medicines.
Cardinal Drug Limited (CDL) is a Public Limited Indian Non-Government Company incorporated in India on 14 January 1993 and has a history of 32 years and two months. Its registered office is in Gwalior, Madhya Pradesh, India.
The Corporate was formerly known as Gwalior Fluorochem Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.60 Cr and a paid-up capital of Rs 4.98 Cr.
The company currently has active open charges totaling ₹13.10 Cr. The company has closed loans amounting to ₹8.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Somani, Sunil Kala, and Geetika Somani serve as directors at the Company.
Gwalior, Madhya Pradesh, India
+91-XXXXXXXXXX
U24114MP1993PLC007463
007463
Public Limited Indian Non-Government Company
14 Jan 1993
30 Sep 2023
31 Mar 2023
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anil Somani ![]() | Director | 14-Jan-1993 | Current |
Sunil Kala ![]() | Director | 01-Sep-1993 | Current |
Geetika Somani ![]() | Director | 14-Jan-1993 | Current |
Cardinal Drug Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 175.3% increase. The company also saw a substantial fall in profitability, with a 878.48% decrease in profit. The company's net worth dipped by a decrease of 2.54%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Cardinal Drug had a promoter holding of 87.60% and a public holding of 12.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sunil Kala is a mutual person
Sunil Kala is a mutual person
Anil Somani and Sunil Kala are mutual person
Anil Somani is a mutual person
Sunil Kala is a mutual person
Sunil Kala is a mutual person
₹13.10 Cr
₹8.50 Cr
Date | Lender | Amount | Status |
---|---|---|---|
01 May 1997 | State Bank Of India | ₹7.60 Cr | Open |
29 Jan 1997 | State Bank Of India | ₹4.60 Cr | Open |
08 Jan 1997 | M. P. Financial Corporation | ₹9.00 M | Open |
29 Oct 1996 | M. P. Financial Corporation | ₹9.00 M | Satisfied |
26 May 1995 | State Bank Of India | ₹7.60 Cr | Satisfied |
Unlock and access historical data on people associated with Cardinal Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cardinal Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardinal Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cardinal Drug Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Cardinal Drug Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.
A charge registered on 26 May 1995 via Charge ID 90201624 with State Bank Of India was fully satisfied on 28 Jul 2006.
A charge registered on 29 Oct 1996 via Charge ID 90210435 with M. P. Financial Corporation was fully satisfied on 26 May 2006.
A charge with M. P. Financial Corporation of Rs. 0.90 Cr registered on 29 Oct 1996 with Charge ID 90210435 was modified on 11 Aug 1997.
A charge with State Bank Of India of Rs. 7.60 Cr registered on 26 May 1995 with Charge ID 90201624 was modified on 11 Aug 1997.
Cardinal Drug Limited was incorporated on 14 Jan 1993.
The authorized share capital of Cardinal Drug Limited is ₹ 6.60 Cr and paid-up capital is ₹ 4.98 Cr.
Currently 3 directors are associated with Cardinal Drug Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cardinal Drug Limited is C/O Mercantile Agencies Jayendra Ganj India, Gwalior, Madhya Pradesh, 474002.
The corporate identification number (CIN) of Cardinal Drug Limited is U24114MP1993PLC007463 and the company number is 007463 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Cardinal Drug Limited has risen by 175.30%.
The financial reports for the fiscal year 2023 indicates that The net worth of Cardinal Drug Limited has experienced an downturn of -2.54%.
As per the financial statements for fiscal Year 2023, The total open charges for Cardinal Drug Limited amount to ₹ 13.10 Cr.
The most recent Balance Sheet for Cardinal Drug Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.